AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories By: Benzinga via Benzinga October 17, 2024 at 08:49 AM EDT On CNBC's “Mad Money Lightning Round,” Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing “very, very well.” ... Read More >> Related Stocks: AbbVie Abbott Laboratories Clover Health Investments, Corp. - Class A Common stock Core Scientific, Inc. - Common Stock GXO Logistics, Inc. Common Stock NEWS Oracle Corp Palantir Technologies Inc. - Class A Common Stock Sirius International Insurance Group, Ltd. - Common Share